Abstract
Goodpasture disease (Goodpasture syndrome, anti-GBM disease) is a term reserved for cases with pulmonary hemorrhage, rapid progressing glomerulonephritis, and circulating antibodies directed against glomerular basement membrane (anti-GBM) and pulmonary alveoli. It is not a classic systemic vasculitis because lungs and kidneys are the only organs involved.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsBibliography
Hluth DC, Rees AJ. Anti-glomerular basement membrane disease. J Am Soc Nephrol 1999;10:2446–2453.
Kalluri R, Sun MJ, Hudson BG, Neilson EG. The Goodpasture autoantigen: Structural delineation of two immunologically privileged epitopes on alpha 3 (IV) chain of type IV collagen. J Biol Chem 1996;271:9062–9068.
Donaghy M, Rees AJ. Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 1983;2:1390–1393.
Bombassei GJ, Kaplan AA. The association between hydrocarbon exposure and anti-glomerular basement membrane antibody-mediated disease (Goodpasture syndrome). Am J Ind Med 1992;21:141–153.
Little MA, Pusey CD. Rapidly progressive glomerulonephritis: Current and evolving treatment strategies. J Nephrol 2004;17:10–19.
Rights and permissions
Copyright information
© 2006 Springer-Verlag London Limited
About this chapter
Cite this chapter
(2006). Goodpasture Disease. In: Clinical Atlas of Interstitial Lung Disease. Springer, London. https://doi.org/10.1007/978-1-84628-326-0_27
Download citation
DOI: https://doi.org/10.1007/978-1-84628-326-0_27
Publisher Name: Springer, London
Print ISBN: 978-1-84628-320-8
Online ISBN: 978-1-84628-326-0
eBook Packages: MedicineMedicine (R0)